Cormorant Asset Management, LP Portfolio Holdings

Cormorant Asset Management, LP

  • $1.27 Billion
  • Q4 2024

Cormorant Asset Management, LP has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $1.27 Billion distributed in 48 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Moon Lake Immunotherapeutics with a value of $451M, Janux Therapeutics, Inc. with a value of $112M, Arcellx, Inc. with a value of $99M, Edgewise Therapeutics, Inc. with a value of $91M, and Eye Point Pharmaceuticals, Inc. with a value of $62M.

Examining the 13F form we can see an decrease of $161M in the current position value, from $1.43B to 1.27B.

Cormorant Asset Management, LP is based out at Boston, MA

Below you can find more details about Cormorant Asset Management, LP portfolio as well as his latest detailed transactions.

Portfolio value $1.27 Billion
Healthcare: $1.27 Billion

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$1.56B
$451 Million 35.64% of portfolio
8,494,151
Q4 2023 Added 4.32%
$1.5B
$112 Million 8.88% of portfolio
2,100,000
Q4 2024 Added 100.0%
$1.71B
$91 Million 7.18% of portfolio
3,406,534
Q3 2024 Added 13.3%
$1.57B
$42.9 Million 3.39% of portfolio
2,561,600
Q3 2024 Added 58.95%
$1.62B
$30.5 Million 2.41% of portfolio
1,050,000
Q3 2024 Added 147.06%
$557M
$28.1 Million 2.22% of portfolio
1,466,460
Q2 2024 Reduced 14.32%
$1.28B
$27.7 Million 2.19% of portfolio
500,000
Q2 2024 Reduced 76.63%
$784M
$25.4 Million 2.01% of portfolio
1,825,000
Q4 2024 Reduced 21.51%
$1.37B
$7.68 Million 0.61% of portfolio
3,000,000
Q4 2024 New
$651M
$4.15 Million 0.33% of portfolio
593,043
Q3 2022 Reduced 2.48%
$576M
$2.96 Million 0.23% of portfolio
300,000
Q4 2024 New
$328M
$2.8 Million 0.22% of portfolio
254,161
Q4 2024 Reduced 40.5%
$436M
$1.97 Million 0.16% of portfolio
350,000
Q4 2022 Reduced 41.67%

Summary

  • Portfolio
  • No. of Stocks 48
  • Current Value $1.27 Billion
  • Prior Value $1.43 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 8 stocks
  • Additional Purchases 7 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 11 stocks
Track This Portfolio

Track Cormorant Asset Management, LP Portfolio

Follow Cormorant Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email